Literature DB >> 34954744

Barriers to Engagement in Opioid Use Disorder Treatment After Buprenorphine Induction.

Scott A Simpson1, Melissa Hordes, Joshua Blum, Deborah Rinehart, Alia Al-Tayyib.   

Abstract

OBJECTIVES: Expanded access to buprenorphine induction, including via emergency departments, increases the likelihood of treatment engagement for patients with opioid use disorder (OUD). However, longer-term retention among these patients remains a challenge. In this study, we aimed to identify barriers to engaging and retaining patients with OUD in care and additional services that might improve retention.
METHODS: We surveyed counselors at an urban safety net addictions treatment clinic.
RESULTS: Twenty-five of 27 (93%) eligible counselors responded. Counselors described patients who were homeless, had no prior treatment history, or lacked health insurance as hardest to retain in treatment. Housing assistance, residential treatment placement, regular access to a phone, and mental health services were thought to be most beneficial for improving retention. Respondents most often reported that screening for services should happen at intake, and almost all respondents agreed that "retention of patients receiving treatment for OUD would improve with a dedicated case manager and/or more coordinated case management services."
CONCLUSIONS: Engagement in OUD treatment would be improved with interventions to mitigate the significant social and psychiatric comorbidities of addiction. Community- and emergency department-initiated buprenorphine is a promising intervention whose full promise cannot be realized without interventions to improve treatment retention.
Copyright © 2021 American Society of Addiction Medicine.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34954744      PMCID: PMC9549700          DOI: 10.1097/ADM.0000000000000943

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  10 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.

Authors:  Gail D'Onofrio; Marek C Chawarski; Patrick G O'Connor; Michael V Pantalon; Susan H Busch; Patricia H Owens; Kathryn Hawk; Steven L Bernstein; David A Fiellin
Journal:  J Gen Intern Med       Date:  2017-02-13       Impact factor: 5.128

3.  The impact of mental health comorbidities on adherence to buprenorphine: A claims based analysis.

Authors:  Megan Litz; Douglas Leslie
Journal:  Am J Addict       Date:  2017-11-16

Review 4.  Linkage-to-care Methods and Rates in U.S. Emergency Department-based HIV Testing Programs: A Systematic Literature Review Brief Report.

Authors:  Aravind A Menon; Carolyn Nganga-Good; Mikeeo Martis; Cassie Wicken; Katie Lobner; Richard E Rothman; Yu-Hsiang Hsieh
Journal:  Acad Emerg Med       Date:  2016-07       Impact factor: 3.451

5.  Monitoring opioid addiction and treatment: Do you know if your population is engaged?

Authors:  José Tomás Prieto; Dean McEwen; Arthur J Davidson; Alia Al-Tayyib; Lisa Gawenus; Sridhar R Papagari Sangareddy; Joshua Blum; Seth Foldy; Judith C Shlay
Journal:  Drug Alcohol Depend       Date:  2019-07-06       Impact factor: 4.492

6.  Long-Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine.

Authors:  Cristina Montalvo; Brad Stankiewicz; Annelise Brochier; David C Henderson; Christina P C Borba
Journal:  Am J Addict       Date:  2019-05-08

7.  Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder.

Authors:  Naoko A Ronquest; Tina M Willson; Leslie B Montejano; Vijay R Nadipelli; Bernd A Wollschlaeger
Journal:  Subst Abuse Rehabil       Date:  2018-09-21

8.  Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.

Authors:  Margo E Godersky; Andrew J Saxon; Joseph O Merrill; Jeffrey H Samet; Jane M Simoni; Judith I Tsui
Journal:  Addict Sci Clin Pract       Date:  2019-03-13

9.  American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.

Authors:  Kyle Kampman; Margaret Jarvis
Journal:  J Addict Med       Date:  2015 Sep-Oct       Impact factor: 3.702

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.